✦ LIBER ✦

Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study

✍ Scribed by Manuel Constenla; Ramon Garcia-Arroyo; Isabel Lorenzo; Nancy Carrete; Begoña Campos; Patricia Palacios

Publisher: Springer
Year: 2002
Tongue: English
Weight: 78 KB
Volume: 5
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s101200200025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of paclitaxel combined

A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer

✍ Chong Kun Im; Hei-Cheul Jeung; Sun Young Rha; Nae Choon Yoo; Sung Hoon Noh; Jae 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB

Combination docetaxel (Taxotere), fluoro

Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study

✍ Pavlos Papakostas; Dimitrios Tsavdaridis; Paris Kosmidis; Haralabos P. Kalofonos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 333 KB

Randomized phase II study of sequential

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

✍ Michael Gubanski; Anders Johnsson; Eva Fernebro; Lianna Kadar; Ingegerd Karlberg 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Neoadjuvant chemotherapy in advanced gas

Neoadjuvant chemotherapy in advanced gastric cancer with non-curative factors: a Phase II study with 5-fluorouracil, leucovorin, and cisplatin

✍ Atsushi Nashimoto; Hiroshi Yabusaki; Otsuo Tanaka; Juei Sasaki; Nobuhiro Akiyama 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 100 KB

Phase II study of biweekly docetaxel and

Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer

✍ Chikara Kunisaki; Masazumi Takahashi; Hirochika Makino; Takashi Oshima; Shoichi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 272 KB

A phase II trial of 5-fluorouracil, doxo

A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma

✍ Susan G. Arbuck; Yusuf Silk Md; Harold O. Douglass Jr.; Hector Nava; Youcef M. R 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

To determine the feasibility and toxicity of combining leucovorin (CF) with a 5fluorouracil(5-FU) combination chemotherapy regimen currently accepted by many as standard treatment for gastric cancer, CF (500 mg/m') was administered in combination with the Georgetown S-FU, doxorubicin, and mitomycin